Injective Foundation operates a layer-2 decentralized exchange (DEX) protocol that enables unlimited decentralized finance markets focused on derivatives, futures, perpetuals, and spot trading. It achieves this by running a cross-chain, layer-2 platform that conducts secure, instant, and borderless trades, with fees earned from transactions and staking services. The platform targets traders ranging from novices to professionals by offering a user-friendly interface plus advanced trading features. Compared to competitors, Injective distinguishes itself with its scalable, cross-chain L2 design that supports a wide range of markets directly on the blockchain, reducing reliance on centralized intermediaries. Its goal is to unlock the full potential of decentralized derivatives and DeFi trading by providing secure, high-throughput, and borderless access to diverse markets.
Company Size
51-200
Company Stage
Late Stage VC
Total Funding
$52.6M
Headquarters
New York City, New York
Founded
2018
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?